• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔癌中叶酸转运蛋白表达降低。

Decreased expression of folate transport proteins in oral cancer.

机构信息

Department of Anatomy, Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL, USA.

William Carey University, College of Osteopathic Medicine, Hattiesburg, MS, USA.

出版信息

Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 May;127(5):417-424. doi: 10.1016/j.oooo.2018.09.005. Epub 2018 Sep 26.

DOI:10.1016/j.oooo.2018.09.005
PMID:30853412
Abstract

OBJECTIVES

The purpose of this study was to assess the expression of the 3 major folate transporters-folate receptors (FRs), reduced folate carrier (RFC), and proton-coupled folate transporter (PCFT)-in oral squamous cell carcinoma (OSCC). We hypothesized that patterns of expression of folate transporters would be different in OSCC compared with normal oral epithelium.

STUDY DESIGN

We used immunohistochemistry to examine the expression of FR, RFC, and PCFT in 15 primary specimens collected from patients with OSCC, 2 human cadaveric samples of OSCC, and 12 normal human cadaveric oral tissues from a medical gross anatomy laboratory. Possible correlations between the expression of each folate transporter and patients' clinical data were determined.

RESULTS

All 3 folate transporters were highly expressed in normal oral epithelium. In contrast, OSCC samples generally demonstrated low expression of FR, RFC, and PCFT, with wide distribution in the invading cancer cells. There were no differences in folate transporter expression between OSCC samples collected from patients and from human cadavers. The lowest expression of FR and PCFT characterized less-differentiated tumors, and the lowest expression of RFC correlated with higher lymph node involvement.

CONCLUSIONS

Human oral cancer samples expressed decreased amounts of all 3 major folate transport proteins compared with controls from normal cadaveric oral tissues.

摘要

目的

本研究旨在评估叶酸转运体(叶酸受体 [FR]、还原叶酸载体 [RFC]和质子偶联叶酸转运体 [PCFT])在口腔鳞状细胞癌(OSCC)中的表达。我们假设 FR、RFC 和 PCFT 的表达模式在 OSCC 中与正常口腔上皮组织不同。

研究设计

我们使用免疫组织化学方法检测了 15 例来自 OSCC 患者的原发性标本、2 例人类 OSCC 尸检标本和 12 例来自医学大体解剖实验室的正常人类尸检口腔组织中 FR、RFC 和 PCFT 的表达。确定了每种叶酸转运体的表达与患者临床数据之间的可能相关性。

结果

所有 3 种叶酸转运体在正常口腔上皮组织中均高度表达。相比之下,OSCC 样本通常表现出 FR、RFC 和 PCFT 的低表达,在侵袭性癌细胞中广泛分布。来自患者和尸检的 OSCC 样本之间的叶酸转运体表达没有差异。FR 和 PCFT 的表达最低与分化程度较低的肿瘤有关,而 RFC 的表达最低与更高的淋巴结受累相关。

结论

与来自正常尸检口腔组织的对照相比,人类口腔癌样本中所有 3 种主要叶酸转运蛋白的表达量均降低。

相似文献

1
Decreased expression of folate transport proteins in oral cancer.口腔癌中叶酸转运蛋白表达降低。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 May;127(5):417-424. doi: 10.1016/j.oooo.2018.09.005. Epub 2018 Sep 26.
2
The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.主要促进叶酸转运蛋白溶质载体 19A1 和溶质载体 46A1:生物学及在癌症抗叶酸化疗中的作用。
Drug Metab Dispos. 2014 Apr;42(4):632-49. doi: 10.1124/dmd.113.055723. Epub 2014 Jan 6.
3
Folate transporter dynamics and therapy with classic and tumor-targeted antifolates.叶酸转运体动力学以及经典和肿瘤靶向性抗叶酸药物治疗
Sci Rep. 2021 Mar 18;11(1):6389. doi: 10.1038/s41598-021-85818-x.
4
Biology of the major facilitative folate transporters SLC19A1 and SLC46A1.主要易化型叶酸转运蛋白SLC19A1和SLC46A1的生物学特性
Curr Top Membr. 2014;73:175-204. doi: 10.1016/B978-0-12-800223-0.00004-9.
5
Enhanced receptor-mediated endocytosis and cytotoxicity of a folic acid-desacetylvinblastine monohydrazide conjugate in a pemetrexed-resistant cell line lacking folate-specific facilitative carriers but with increased folate receptor expression.培美曲塞耐药细胞系中缺乏叶酸特异性易化载体但叶酸受体表达增加的情况下,叶酸-去乙酰长春碱单水合物缀合物的增强的受体介导的内吞作用和细胞毒性。
Mol Pharmacol. 2014 Feb;85(2):310-21. doi: 10.1124/mol.113.089110. Epub 2013 Nov 18.
6
Regulation of folate transport at the mouse arachnoid barrier.调控鼠软脑膜屏障的叶酸转运。
Fluids Barriers CNS. 2024 Aug 27;21(1):67. doi: 10.1186/s12987-024-00566-0.
7
Folate transporter expression in placenta from pregnancies complicated with birth defects.叶酸转运体在伴有出生缺陷的妊娠胎盘中的表达。
Birth Defects Res. 2018 Oct 2;110(16):1223-1227. doi: 10.1002/bdr2.1356. Epub 2018 Jul 31.
8
Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier for cellular entry.新型 6-取代吡咯并[2,3-d]嘧啶噻吩甲酰基抗叶酸物抑制剂的合成及抗肿瘤活性,该抑制剂可优先与高亲和力叶酸受体和质子偶联叶酸转运体结合,而不是与还原叶酸载体结合进入细胞,从而进行嘌呤生物合成。
J Med Chem. 2010 Feb 11;53(3):1306-18. doi: 10.1021/jm9015729.
9
Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells.叶酸受体和还原型叶酸载体在人卵巢癌细胞中5-甲基四氢叶酸转运中的作用
Int J Cancer. 1998 Jan 5;75(1):125-33. doi: 10.1002/(sici)1097-0215(19980105)75:1<125::aid-ijc19>3.0.co;2-f.
10
Reduced levels of folate transporters (PCFT and RFC) in membrane lipid rafts result in colonic folate malabsorption in chronic alcoholism.膜脂筏中叶酸转运蛋白(PCFT 和 RFC)水平降低导致慢性酒精中毒时结肠叶酸吸收不良。
J Cell Physiol. 2011 Mar;226(3):579-87. doi: 10.1002/jcp.22525.

引用本文的文献

1
Combating Methotrexate Resistance in Cancer Treatment: A Review on Navigating Pathways and Enhancing Its Efficacy With Fat-Soluble Vitamins.癌症治疗中对抗甲氨蝶呤耐药性:关于通过脂溶性维生素探寻途径并提高其疗效的综述
Scientifica (Cairo). 2025 Apr 16;2025:8259470. doi: 10.1155/sci5/8259470. eCollection 2025.